Literature DB >> 730356

Formation of antibody to matrix protein in experimental human influenza A virus infections.

L Cretescu, A S Beare, G C Schild.   

Abstract

Antibodies to type A influenza virus matrix protein (M) were assayed by single radial diffusion in 180 paired sera of volunteers challenged intranasally with live H3N2 viruses of varying degrees of virulence. Of these volunteers 20 had had severe clinical reactions (influenza-like); there had been 19 moderate reactions (lesser degrees of constitutional illness), and the remaining 141 reactions had been graded mild, very mild, or nil. Only 2 volunteers were shown to have antibodies to M in the pre-trial serum samples, and 11 developed anti-M rises after virus inoculation. Nine of the 11 had had severe reactions, and 2 had had moderate reactions. There was, therefore, a clear correlation between severity of clinical illness and anti-M antibody formation. In general, anti-M increases coincided with increases to the hemagglutinins and nucleoprotein, and with virus shedding. However, no anti-M antibody could be demonstrated in paired sera of 18 additional volunteers of whom 12 had developed severe reactions after the inoculation of virulent H0N1 and H1N1 influenza A viruses and of whom 12 had shown laboratory evidence of infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 730356      PMCID: PMC422157          DOI: 10.1128/iai.22.2.322-327.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  The production of live attenuated influenza A strains by recombination with A/Okuda/57 (H2N2).

Authors:  D McCahon; A S Beare; V Stealey
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

2.  Immunological and physicochemical studies of influenza matrix (M) polypeptides.

Authors:  J S Oxford; G C Schild
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

3.  A quantitative, single-radial-diffusion test for immunological studies with influenza virus.

Authors:  G C Schild; M Henry-Aymard; H G Pereira
Journal:  J Gen Virol       Date:  1972-08       Impact factor: 3.891

4.  Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.

Authors:  B R Murphy; E G Chalhub; S R Nusinoff; R M Chanock
Journal:  J Infect Dis       Date:  1972-08       Impact factor: 5.226

5.  Application of the single radial diffusion test for assay of antibody to influenza type A viruses.

Authors:  S R Mostow; G C Schild; W R Dowdle; R J Wood
Journal:  J Clin Microbiol       Date:  1975-12       Impact factor: 5.948

6.  Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses.

Authors:  A S Beare; G C Schild; J W Craig
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

7.  Matrix protein from influenza A virus and its role in cross-protection in mice.

Authors:  R G Webster; V S Hinshaw
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

8.  Recombinant influenza-A viruses as live vaccines for man. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines.

Authors:  A S Beare; T S Hall
Journal:  Lancet       Date:  1971-12-11       Impact factor: 79.321

9.  INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.

Authors:  J L SCHULMAN; E D KILBOURNE
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

10.  Antibody to influenza virus matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses.

Authors:  W E Biddison; P C Doherty; R G Webster
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  10 in total

1.  Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.

Authors:  Matthew J Memoli; Lindsay Czajkowski; Susan Reed; Rani Athota; Tyler Bristol; Kathleen Proudfoot; Sarah Fargis; Matthew Stein; Rebecca L Dunfee; Pamela A Shaw; Richard T Davey; Jeffery K Taubenberger
Journal:  Clin Infect Dis       Date:  2014-11-20       Impact factor: 9.079

2.  Detection of antibodies to influenza virus M protein by an enzyme-linked immunosorbent assay.

Authors:  M W Khan; D J Bucher; A K Koul; G Kalish; H Smith; E D Kilbourne
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

3.  Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.

Authors:  Mark W Lamere; Amy Moquin; F Eun-Hyung Lee; Ravi S Misra; Patrick J Blair; Laura Haynes; Troy D Randall; Frances E Lund; Denise A Kaminski
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

4.  Antigenic relationships between measles and canine distemper viruses: comparison of immune response in animals and humans to individual virus-specific polypeptides.

Authors:  J R Stephenson; V ter Meulen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

5.  Measurement of antibodies to influenza virus neuraminidase by an enzyme-linked immunosorbent assay.

Authors:  K A Callow
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Anti M-protein antibody response to type A or B natural influenza detected by solid phase enzyme linked immunosorbent assay and by complement fixation.

Authors:  L Joassin; M Reginster; D Vaira
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

7.  Human trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978.

Authors:  A S Beare; A P Kendal; N J Cox; C Scholtissek
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

Review 8.  The human antibody response to influenza A virus infection and vaccination.

Authors:  Florian Krammer
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

9.  Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design.

Authors:  Denise A Kaminski; F Eun-Hyung Lee
Journal:  Front Immunol       Date:  2011-12-16       Impact factor: 7.561

10.  Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants.

Authors:  U Kees; P H Krammer
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.